Treatment of Neurogenic Detrusor Overactivity after Spinal Cord Injury Using Botulinum A Toxin. Comparison of Endoscopic Submucosal and Intramuscular Route of Application
Authors: V. Šámal, J. Mečl, J. Šrám
Authors - sphere of activity: Krajská nemocnice Liberec, a.s.: 1 Urologické oddělení, 2 Traumatologicko-ortopedické centrum, Spinální jednotka
Article: Cesk Slov Neurol N 2012; 75/108(2): 197-202
Category: Original Paper
Number of articles displayed: 343x
Treatment of neurogenic detrusor overactivity using botulinum A toxin is currently the approach of choice in patients refractory to antimuscarinic drugs. This study compares the changes of urodynamic parameters with different routes of botulinum A toxin administration – submucosal and intramuscular. The study monitors changes in selected urodynamic parameters and the number of incontinence episodes as well as an improvement in the quality of life.
Material and methods:
Fifteen patients with neurogenic detrusor overactivity after spinal cord injury aged 25 to 46 year were randomized into two groups to receive 300 U of botulinumtoxin (Botox®) by cystoscopic approach. In group A, the drug submucosaly and it was administered into detrusor in group B. Urodynamic parameters and the quality of life were evaluated before and 12 weeks after the treatment.
The authors present results obtained from 15 patients. The number of incontinence episodes decreased after the treatment in about 77% of patients in both groups. Maximum cystometric capacity increased from 236.6 ±76.1 ml to 456 ±73.8 ml in the group with submucosal application (p <0.05) and from 242.7 ±96.8 ml to 432.8 ±79.1 ml in the group with the application into detrusor (p <0.05). Maximum detrusor pressure during involuntary contraction decreased (p <0.05).
Administration of botulinum A toxin within 3 months after treatment increased the maximum cystometric capacity, decreased maximum detrusor pressure during involuntary detrusor contraction and reduced the number of incontinence episodes. These preliminary results suggest that both methods of administration are comparable.
botulinum toxin – detrusor overactivity – incontinence – submucosal application
The full wording of this article is available only to registered users. Plese register and you can read this article immediately.
If you are a subscriber, log in and enter the subscriber code from your magazine cover.
If you are not a subscriber, log in for unlimited access to older editions.
Tento článek si můžete přečíst pokud si aktivujete Premium účet.
SubscriptionSubscribe the Journal
The subscription grants you full access to all the articles.
Issue No.: 3 / 2013
- Creutzfeldt-Jacob disease | views: 126
- Spinocerebellar Ataxia 7 – a Case Report | views: 59
- Electrophysiological Examination of the Pelvic Floor | views: 49
- Ultrasound-guided Brain Cavernoma Surgery | views: 43
- Differences in the Modulation of Cortical Activity in Patients Suffering from Upper Arm Spasticity Following Stroke and Treated with Botulinum Toxin A | views: 34
- Torticollis at Grisel’s Syndrome – Case Reports | views: 30
- X-adrenoleukodystrophy | views: 26
- Significance and Limitations of Visual Evoked Potentials in the Study of Pathophysiology of Migraine | views: 25
- Evaluation of Epidemiological Stroke Data from the IKTA Register. Stroke Incidence in the Zlin District | views: 25
- The Role of a Neurootologist in Identification of Post-radiation Complications in Patients with Vestibular Schwannoma Treated with Leksell Gamma Knife | views: 19